181 related articles for article (PubMed ID: 11562835)
1. [Dopaminomimetic psychosis in Parkinson's disease: first symptom of early dementia?].
Catalan-Alonso MJ; Del Val J
Rev Neurol; 2001 Jun 1-15; 32(11):1085-7. PubMed ID: 11562835
[TBL] [Abstract][Full Text] [Related]
2. Dopaminomimetic psychosis in Parkinson's disease patients: diagnosis and treatment.
Wolters EC
Neurology; 1999; 52(7 Suppl 3):S10-3. PubMed ID: 10227604
[TBL] [Abstract][Full Text] [Related]
3. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
[TBL] [Abstract][Full Text] [Related]
4. Clozapine prevents recurrence of psychosis in Parkinson's disease.
Factor SA; Brown D
Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059
[TBL] [Abstract][Full Text] [Related]
5. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
[TBL] [Abstract][Full Text] [Related]
6. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
Reddy S; Factor SA; Molho ES; Feustel PJ
Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
[TBL] [Abstract][Full Text] [Related]
7. [Exogenous psychoses in Parkinson syndrome. Frequency and causal conditions].
Schneider E; Fischer PA; Jacobi P; Grotz A
Fortschr Neurol Psychiatr; 1984 Jun; 52(6):207-14. PubMed ID: 6745832
[TBL] [Abstract][Full Text] [Related]
8. Psychosis in Parkinson's disease.
Poewe W
Mov Disord; 2003 Sep; 18 Suppl 6():S80-7. PubMed ID: 14502660
[TBL] [Abstract][Full Text] [Related]
9. [Hallucinations in Parkinson's disease].
Moser A; Hagenah J; Kömpf D
Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
[TBL] [Abstract][Full Text] [Related]
10. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
Abbar M; Courtet P; Castelnau D
Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
[TBL] [Abstract][Full Text] [Related]
11. [Ziprasidone in Parkinsonian dopamine psychosis].
Durán-Ferreras E; Alvarez-López M; García-Moreno JM; Chacón J
Rev Neurol; 2008 Apr 16-30; 46(8):476-80. PubMed ID: 18428105
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease: drug-induced psychiatric states.
Factor SA; Molho ES; Podskalny GD; Brown D
Adv Neurol; 1995; 65():115-38. PubMed ID: 7872135
[TBL] [Abstract][Full Text] [Related]
13. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
Normann C; Hesslinger B; Frauenknecht S; Berger M; Walden J
Pharmacopsychiatry; 1997 Nov; 30(6):263-5. PubMed ID: 9442549
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.
Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
Friedman JH; Factor SA
Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
Parkinson Study Group CALM Cohort Investigators
Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic psychosis in advanced Parkinson's disease.
Fischer P; Danielczyk W; Simanyi M; Streifler MB
Adv Neurol; 1990; 53():391-7. PubMed ID: 2122647
[No Abstract] [Full Text] [Related]
18. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
[TBL] [Abstract][Full Text] [Related]
19. Levodopa/dopamine replacement strategies in Parkinson's disease--future directions.
Olanow CW
Mov Disord; 2008; 23 Suppl 3():S613-22. PubMed ID: 18781663
[TBL] [Abstract][Full Text] [Related]
20. Optimizing long-term therapy for Parkinson disease: levodopa, dopamine agonists, and treatment-associated dyskinesia.
Stacy M; Galbreath A
Clin Neuropharmacol; 2008; 31(1):51-6. PubMed ID: 18303491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
